(S)-2-(N,N-dibenzylamino)-3-(4'-benzyloxyphenyl)-propionaldehyde | 153290-54-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (S)-2-(N,N-dibenzylamino)-3-(4'-benzyloxyphenyl)-propionaldehyde
• 英文别名: (S)-3-(4-Benzyloxyphenyl)-2-(dibenzylamino)propanal；(2S)-2-(dibenzylamino)-3-(4-phenylmethoxyphenyl)propanal
• CAS: 153290-54-1
• 化学式: C₃₀H₂₉NO₂
• 分子量: 435.566
• InChiKey: UBNRYFHVXKUNLV-LJAQVGFWSA-N

物化性质

• 沸点：
  565.6±50.0 °C(predicted)
• 密度：
  1.137±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  6.2
• 重原子数：
  33
• 可旋转键数：
  11
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  29.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (S)-2-(N,N-dibenzylamino)-3-(4'-benzyloxyphenyl)-propionaldehyde 在 palladium dihydroxide 正丁基锂 、 氢气 、 N,N-二异丙基乙胺 作用下， 以 乙醇 、 二氯甲烷 为溶剂， -78.0 ℃ 、689.47 kPa 条件下， 反应 25.0h， 生成
  参考文献：
  名称：

  A novel series of 2-pyridyl-containing compounds as lysophosphatidic acid receptor antagonists: development of a nonhydrolyzable LPA3 receptor-selective antagonist

  摘要：

  A recently reported dual LPA(1)/LPA(3) receptor antagonist (1) has been modified so as to modulate the basicity, sterics, and dipole moment of the 2-pyridyl moiety. Additionally, the implications of installing nonhydrolyzable phosphate head group isosteres with regard to antagonist potency and selectivity at LPA receptors is described. This study has resulted in the development of the first nonhydrolyzable and presumably phosphatase-resistant LPA(3)-selective antagonist reported to date. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.05.023
• 作为产物：
  描述：

  (2S)-Benzyl 3-(4-benzyloxyphenyl)-2-dibenzylaminopropanoate 在 lithium aluminium tetrahydride 、 三氧化硫吡啶 、 三乙胺 作用下， 以 四氢呋喃 、 二甲基亚砜 为溶剂， 反应 2.5h， 生成 (S)-2-(N,N-dibenzylamino)-3-(4'-benzyloxyphenyl)-propionaldehyde
  参考文献：
  名称：

  氨基烷基氯代醇盐酸盐的制备：羟乙胺基HIV蛋白酶抑制剂的关键组成部分。

  摘要：

  对映体纯的N，N-二苄基-α-氨基乙醛与（氯甲基）锂发生反应，从溴氯甲烷和锂金属就地生成，主要生成赤型氨基烷基环氧化物。用盐酸水溶液处理粗环氧化合物，得到结晶（2S，3S）-N，N-二苄基氨基氯醇盐酸盐，总产率为32-56％，且异构体纯度高。这些化合物是用于直接或通过转化为相应的N-Boc-（2S，3S）-氨基烷基环氧化物制备基于羟乙胺的HIV蛋白酶抑制剂的通用合成中间体。所描述的方法不使用危险的试剂或中间体，不需要色谱纯化，因此适合制备大量这些通用模块。

  DOI：

  10.1021/jo960109i

文献信息

• Antitumoral compounds
  申请人：——

  公开号：US20040048834A1

  公开（公告）日：2004-03-11

  New spisulosine derivatives of use in treating tumors are of the formula (I) wherein: each X is the same or different, and represents H, OH, OR′, SH, SR′, SOR′, SO 2 R′, NO 2 , NH 2 , NHR′, N(R′) 2 , CN, halogen, C(═O)H, C(═O)CH 3 , CO 2 H, CO 2 CH 3 , substituted or unsubstituted C 1 -C 18 alkyl, substituted or unsubstituted C 2 -C 18 alkenyl, substituted or unsubstituted C 2 -C 18 alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaromatic, or two groups X may together form ═O; Y is NR 1 , OR 1 , PR 1 , SR 1 , or halogen, wherein the number of substituents R 1 is selected to suit the valency and each R 1 is independently selected of H, OH, C(═O)R′, P(═O)R′R″, substituted or unsubstituted C 1 -C 18 alkyl, substituted or unsubstituted C 2 -C 18 alkenyl, substituted or unsubstituted C 2 -C 18 alkynyl, substituted or unsubstituted aryl, and wherein the dotted line indicates an optional double bond; each Z is the same different, and represents H, OH, OR′, SH, SR′, SOR′, SO 2 R′, NO 2 , NH 2 , NHR′, N(R′) 2 , NHC(O)R′, CN, halogen, C(═O)H, C(═O)CH 3 , CO 2 H, CO 2 CH 3 , substituted or unsubstituted C 1 -C 18 alkyl, substituted or unsubstituted C 2 -C 18 alkenyl, substituted or unsubstituted C 2 -C 18 alkenyl, substituted or unsubstituted C 2 -C 18 alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaromatic, or two groups Z may together form ═O; z is 0 to 25; y is to 0 to 20; R 2 is H, C(═O)R′, P(═O)R′R″, S(═O)R′R″, S(═O) 2 R′, substituted or unsubstituted C 1 -C 18 alkyl, substituted or unsubstituted C 2 -C 18 Alkenyl, substituted or unsubstituted C 2 -C 18 alkynyl, substituted or unsubstituted aryl; R 3 is H, C(═O)R′, P(═O)R′R″, S(═O)R′R″, S(═O) 2 R′, substituted or unsubstituted C 1 -C 18 alklyl, substituted or unsubstituted C 2 -C 18 alkenyl, substituted or unsubstituted C 2 -C 18 alkynyl, substituted or unsubstituted aryl; each of the R′, R″ groups is independently selected from the group consisting of H, OH, NO 2 , NH 2 , SH, CN, halogen, ═O, C(═O)H, C(═O)CH 3 , CO 2 H, CO 2 CH 3 , substituted or unsubstituted C 1 -C 18 alkyl, substituted or unsubstituted C 1 -C 18 alkoxy, substituted or unsubstituted C 2 -C 18 alkenyl, substituted or unsubstituted C 2 -C 18 alkynl, substituted or unsubstituted aryl; there may be one or more unsaturations in the hydrocarbon backbone defined by the chain (II) and salts thereof; with the exception of a C 16 -C 24 2-amino-3-hydroxyalkane or a C 16 -C 24 2-amino-3-hydroxyalkene.

  新的用于治疗肿瘤的斯皮苏林衍生物的化学式为（I），其中：每个X相同或不同，表示H、OH、OR′、SH、SR′、SOR′、SO2R′、NO2、NH2、NHR′、N(R′)2、CN、卤素、C(═O)H、C(═O)CH3、CO2H、CO2 、取代或未取代的C1-C18烷基、取代或未取代的C2-C18烯基、取代或未取代的C2-C18炔基、取代或未取代的芳基、取代或未取代的杂芳基，或两个X基团可能共同形成═O；Y为NR1、OR1、PR1、SR1或卤素，其中取代基R1的数量选择以适应化合价，每个R1独立选择自H、OH、C(═O)R′、P(═O)R′R″、取代或未取代的C1-C18烷基、取代或未取代的C2-C18烯基、取代或未取代的C2-C18炔基、取代或未取代的芳基，虚线表示可选的双键；每个Z相同或不同，表示H、OH、OR′、SH、SR′、SOR′、SO2R′、 、NH2、NHR′、N(R′)2、NHC(O)R′、CN、卤素、C(═O)H、C(═O) 、CO2H、CO2 、取代或未取代的C1-C18烷基、取代或未取代的C2-C18烯基、取代或未取代的C2-C18炔基、取代或未取代的芳基、取代或未取代的杂芳基，或两个Z基团可能共同形成═O；z为0至25；y为0至20；R2为H、C(═O)R′、P(═O)R′R″、S(═O)R′R″、S(═O)2R′、取代或未取代的C1-C18烷基、取代或未取代的C2-C18烯基、取代或未取代的C2-C18炔基、取代或未取代的芳基；R3为H、C(═O)R′、P(═O)R′R″、S(═O)R′R″、S(═O)2R′、取代或未取代的C1-C18烷基、取代或未取代的C2-C18烯基、取代或未取代的C2-C18炔基、取代或未取代的芳基；每个R′、R″基团独立选择自H、OH、 、NH2、SH、CN、卤素、═O、C(═O)H、C(═O) 、CO2H、CO2 、取代或未取代的C1-C18烷基、取代或未取代的C1-C18烷氧基、取代或未取代的C2-C18烯基、取代或未取代的C2-C18炔基、取代或未取代的芳基；碳链（II）中的碳氢骨架中可能存在一个或多个不饱和度，及其盐；除了C16-C242-氨基-3-羟基烷或C16-C242-氨基-3-羟基烯。
• Diastereoselective Aldol Reaction of <i>N</i>,<i>N</i>-Dibenzyl-α-amino Aldehydes with Ketones Catalyzed by Proline
  作者：Qiangbiao Pan、Benli Zou、Yuji Wang、Dawei Ma

  DOI：10.1021/ol049927k

  日期：2004.3.1

  [reaction: see text] L-proline-catalyzed direct aldol reaction of L-amino acid-derived N,N-dibenzyl amino aldehydes with acetone, cyclopentanone, or hydroxyacetone provides gamma-amino-beta-hydroxy- or gamma-amino-alpha,beta-dihydroxy-ketones with moderate to excellent yields and diastereoselectivities.

  [反应：参见正文] L-脯氨酸催化的L-氨基酸衍生的N，N-二苄基氨基醛与丙酮，环戊酮或羟基丙酮的直接羟醛反应可提供γ-氨基-β-羟基或γ-氨基-α β-二羟基酮，具有中等至优异的收率和非对映选择性。
• Synthesis and Opioid Activity of Tyr¹-<i>ψ</i>[(<i>Z</i>)CF=CH]-Gly²and Tyr¹-<i>ψ</i>[(<i>S</i>)/(<i>R</i>)-CF₃CH-NH]-Gly²Leu-enkephalin Fluorinated Peptidomimetics
  作者：Somnath Narayan Karad、Mohan Pal、Rachel S. Crowley、Thomas E. Prisinzano、Ryan A. Altman

  DOI：10.1002/cmdc.201700103

  日期：2017.4.20

  We describe the design, synthesis, and opioid activity of fluoroalkene (Tyr1 -ψ[(Z)CF=CH]-Gly2 ) and trifluoroethylamine (Tyr1 -ψ[(S)/(R)-CF3 CH-NH]-Gly2 ) analogues of the endogenous opioid neuropeptide, Leu-enkephalin. The fluoroalkene peptidomimetic exhibited low nanomolar functional activity (5.0±2 nm and 60±15 nm for δ- and μ-opioid receptors, respectively) with a μ/δ-selectivity ratio that mimics

  我们描述了氟代烯烃（Tyr1-ψ[（Z）CF = CH] -Gly2）和三氟乙胺（Tyr1-ψ[（S）/（R）-CF3 CH-NH] -Gly2）的设计，合成和阿片类活性内源性阿片类神经肽类似物亮脑啡肽的类似物。氟代烯烃拟肽表现出低的纳摩尔功能活性（对于δ和μ阿片受体分别为5.0±2 nm和60±15 nm），其μ/δ选择性比与天然肽类似。然而，无论立体化学如何，三氟乙胺拟肽都不会激活阿片样物质受体，这表明在该位置不容忍大体积的 取代基。
• Synthesis and identification of unprecedented selective inhibitors of CK1ε
  作者：Gastón Silveira-Dorta、Inês J. Sousa、Miguel X. Fernandes、Victor S. Martín、José M. Padrón

  DOI：10.1016/j.ejmech.2015.03.046

  日期：2015.5

  A small and structure-biased library of enantiopure anti-beta-amino alcohols was prepared in a straightforward manner by a simplified version of the Reetz protocol. Antiproliferative activity testing against a panel of five human solid tumor cell lines gave GI(50) values in the range 1-20 mu M. The reverse screening by computational methods against 58 proteins involved in cancer pointed to kinases as possible therapeutic target candidates. The experimental determination of the interaction with 456 kinases indicated that the compounds behave as selective CK1 epsilon inhibitors. Our results demonstrate that the lead compound represents the first selective CK1 epsilon inhibitor with proven antiproliferative activity in cancer cell lines. (C) 2015 Elsevier Masson SAS. All rights reserved.
• KHMDS/Triglyme Cryptate as an Alternative to Phosphazene Base in Stereodivergent Pentafluoroethylation of <i>N</i>-Sulfinylimines Using HFC-125
  作者：Yuji Sumii、Hiroto Iwasaki、Yamato Fujihira、Elsayed M. Mahmoud、Hiroaki Adachi、Takumi Kagawa、Dominique Cahard、Norio Shibata

  DOI：10.1021/acs.joc.2c01821

  日期：2022.12.2